Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. - Wikidata - wikimedia - TriplyDB

Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.

Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.

http://www.wikidata.org/entity/Q34119481

about

Salmonella as a vaccine delivery vehicle Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model The delicate balance in genetically engineering live vaccines.Improving Salmonella vector with rec mutation to stabilize the DNA cargoes.Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Development of Streptococcus pneumoniae Vaccines Using Live Vectors Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague New technologies in developing recombinant attenuated Salmonella vaccine vectors.Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains.Assessment of attenuated Salmonella vaccine strains in controlling experimental Salmonella Typhimurium infection in chickens.Evaluation of the immunogenicity of Campylobacter jejuni CjaA protein delivered by Salmonella enterica sv. Typhimurium strain with regulated delayed attenuation in chickens.Serotype-independent pneumococcal vaccines.Vaccination against Salmonella Infection: the Mucosal Way.Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated Salmonella enterica Serovar Typhimurium Vaccine Strains.Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens.Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs.Salmonella Vaccines: Conduits for Protective Antigens.Conversion of RpoS- Attenuated Salmonella enterica Serovar Typhi Vaccine Strains to RpoS+ Improves Their Resistance to Host Defense Barriers.Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence

P2860

Q27011946-BA27FC44-3D65-4261-BA00-336CEC2B1B10 Q33710976-39ACA2C7-89B1-4C1F-A422-44FE80DDD8B2 Q33801051-EBB6B13A-D113-4A9E-8A5B-642F212096EF Q33814907-988EDC36-0512-4077-95ED-C0E61E5D8C0A Q33834427-7A26A889-F5D2-4F9B-A2F0-5C5FD4FD54CE Q34298699-1E1D70BC-2E8B-4BFE-8EA9-BF52702296BD Q34316015-38F972B3-7B71-440D-BC03-142542E0EA62 Q34529634-D6A68B72-BD2D-4956-99C3-CEBB1217397A Q35059006-CCC34093-30E2-457B-AB32-B1B33ABE0667 Q35273125-61B60E39-6D11-4DC8-B8AC-BADBA813E14F Q35689514-AFCCB4D4-CFBF-448A-8B82-9D751810B713 Q35689518-D2B3491E-EFC5-4D27-A6E5-E4169B841B61 Q36277335-AFE01C06-9C17-4236-A690-AD7AB62ED684 Q36372952-C88240E0-9A0E-4E28-BB59-6BA184AE2BD9 Q36653379-AF84218E-9C40-4D53-B216-2F08B086F8CC Q36911282-11F69AD0-9544-43B2-BA43-E5845EC9B75E Q37123734-6B961857-1FCB-4590-BD17-7A130479BCEE Q37425256-76E81C0E-B427-4402-A0B0-74E0EBDD2254 Q37432124-B9402B47-6F9E-46B7-8F2C-EDC7AB3A0D25 Q38069943-2A10C9B3-E4AC-498B-9883-1EA5FB997FB3 Q39373957-6D1635E7-79FA-4AC1-9A59-79BDFB21199A Q40083818-2912D804-FA9E-4B56-94CE-4ED44D63F079 Q40114957-963A6F49-6072-48FD-B03E-9520E84DFB43 Q41908579-C17618E8-61BE-4463-9E86-4E2A34458575 Q47158759-74931656-7F94-4E59-99AB-27ADD3441761 Q49644946-5B2C4339-337D-45A2-8CBC-6C97590E486E Q53704376-51036955-0A56-4390-A539-F2ADACF9CBBF Q58759445-20BA08F6-015E-4A71-8A11-6111F07C0F01

P2860

Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.

http://www.wikidata.org/entity/Q34119481

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@ast

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@en

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@nl

type

label

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@ast

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@en

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@nl

prefLabel

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@ast

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@en

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@nl

P1433

Q34119481-04523EDA-168B-48D8-BF9C-8D1F4C22EE50

P1476

Q34119481-C00569AD-08C0-4FE2-A974-E21F84AAC14A

P2093

Q34119481-0F5A8A08-F3DF-4E7F-ABEC-6F4B19027FEE

Q34119481-1D392C03-F0AE-4EE9-9D75-FBCFAE231C6D

Q34119481-21FB3708-4CC3-4355-9676-5196E6CBA56F

Q34119481-26D82982-7407-41E9-BE6A-D6058A62E91F

Q34119481-4DB70C86-E80A-4BDC-9E13-152FC52BFA23

Q34119481-75C1D591-E62E-4783-AD38-45C44FDD00A9

Q34119481-76E00275-1731-4F67-9235-EB7305D9E2A9

Q34119481-7A31B438-607D-4C11-B8CD-B7B13AAC8191

Q34119481-92E126FF-24CD-4018-9C61-236928476F53

Q34119481-A4955256-8BA0-4C08-AF66-0D5D6EDC2811

P2860

Q34119481-01A4236E-78D8-44A7-8F22-0802EFEE35A6

Q34119481-0B92EFA6-99B2-4B4E-87FD-4EE9D6D594B9

Q34119481-0FFD3F7E-5357-4060-824F-9918EEB44C45

Q34119481-12B24394-6A4B-45F0-98DB-56658D3AD664

Q34119481-1464DB94-D167-406C-97DD-4D4DD45C69C6

Q34119481-187E3178-553D-44CC-9231-008844913FFA

Q34119481-1A0A4C7A-43A1-40D8-A931-6C51DE599E5C

Q34119481-1DE727A7-3AEE-40AF-836C-D8EDF4D5F9BE

Q34119481-1E4DA203-5B18-4EA4-8F08-4A0819D8DF1C

Q34119481-27DDD0BD-0682-41FE-88D9-D2CA00701729

P304

Q34119481-5C9B9A57-C57A-483D-9237-A9099701064F

P31

Q34119481-B2F40E4E-168F-4C27-8EA6-04836C235E17

P356

Q34119481-F47E8EAF-836C-4772-9A49-49F3216AC4D4

P407

Q34119481-5110A890-ED1E-4D66-BD5B-7D189EA75E6E

P433

Q34119481-59C2717C-1B95-49C7-894E-B3E4C98CC750

P478

Q34119481-2D7C6A71-2219-4810-BF99-169F2BD45FF6

P577

Q34119481-6F0CF75F-C124-4CE2-97E5-0798511CE502

P698

Q34119481-24BB41B7-7FD1-45F5-9FBF-605FCABFE78D

P932

Q34119481-BB441E81-EB32-4844-80C8-FC4770971F78

P356

P1433

Infection and Immunity

P1476

Salmonella vaccine vectors dis ...... ivo to enhance immunogenicity.

@en

P2093

Bronwyn Gunn

http://www.w3.org/2001/XMLSchema#string

Chang-Ho Baek

http://www.w3.org/2001/XMLSchema#string

Giorgio Scarpellini

http://www.w3.org/2001/XMLSchema#string

HuoYing Shi

http://www.w3.org/2001/XMLSchema#string

Kenneth L Roland

http://www.w3.org/2001/XMLSchema#string

Patti Senechal-Willis

http://www.w3.org/2001/XMLSchema#string

Roy Curtiss

http://www.w3.org/2001/XMLSchema#string

Shifeng Wang

http://www.w3.org/2001/XMLSchema#string

Soo-Young Wanda

http://www.w3.org/2001/XMLSchema#string

Wei Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Complete genome sequence of Salmonella enterica serovar Typhimurium LT2

Isolation of the lac repressor

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli

lac repressor is an antivirulence factor of Salmonella enterica: its role in the evolution of virulence in Salmonella.

Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers

A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae

Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

The lac repressor.

Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.

P304

3969-3980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00444-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20605977

http://www.w3.org/2001/XMLSchema#string

P932

2937466

http://www.w3.org/2001/XMLSchema#string